Skip to main content

Table 2 Characteristics of included guidelines and one statement

From: Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

  country Issueing organization name of guideline initial release revisions target patients target users/setting evidence base grading of evidence
         LoE GoR
CEBAM Belgium Belgian Centre for Evidence Based Medici, Cochrane Belgium Chronische Niereninsufficiëntie 2012   adult patients (over 18 years of age) with chronically diminished kidney function general practitioners systematic guideline review, additional systematic searches GRADE
ACP USA American College of Physicians Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the American College of Physicians 2013   target patient population for screening is adults, and the target population for treatment it is adults with stage 1 to 3 CKD clinicians systematic review American College of Physicians grading system, adapted from GRADE
HAS France Haute Autorité de Santé Guide de parcours de soins Maladie Rénale Chronique de l’adulte 2012   Adult patients with chronic kidney disease. Excluded: patients with end stage renal disease, dialysis or transplantation, inpatients. General practitioners, dieticians, nurses, pharmacists, etc., and may also concern other health professionals (Nephrologists, cardiologists, diabetologists, physiotherapists, psychologists) unclear, existing recommendations, expert opinion no formal grading of evidence or level of recommendation
KDIGO USA Kidney Disease Improving Global Outcomes KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease 2012   individuals at risk for or with CKD Providers: Nephrologists (adult and pediatric), dialysis providers(including nurses), Internists, and pediatricians.patients: Adult and pediatric individuals at risk for or with CKD. Policy Makers: Those in related health fields. systematic review GRADE
KHA-CARI Australia, New Zealand Kidney Health Australia, Caring for Australasians with Renal Impairment Early Chronic Kidney Disease 2013   patients with kidney disease in Australia & New Zealand, patients with early chronic kidney disease clinicians and health care workers systematic review GRADE
BCMA Canada British Columbia Medical Association Chronic Kidney Disease - Identification, Evaluation and Management of Adult Patients 2014   adults aged ≥19 years at risk of or with known chronic kidney disease The primary audience for BC Guidelines is British Columbia physicians, nurse practitioners, and medical students. However, other audiences such as health educators, health authorities, allied health organizations, pharmacists, and nurses may also find them to be a useful resource not described no formal grading of evidence or level of recommendation
UMHS USA University of Michigan Health System Management of Chronic Kidney Disease 2005 Interim/minor revision: March, 2014 June, 2016 adults with chronic kidney disease clinicians, primary care poviders systematic review GRADE, not formally stated
VA-DoD USA Department of Veterans Affairs, Department of Defense VA/DoD Clinical Practice Guideline for the Management of Chronic Kidney Disease in Primary Care 2014 adults 18 years or older with CKD 1–4 without kidney transplant primary care providers systematic review GRADE
NICE UK National Institute of Health and Care Excellence Early identification and management of chronic kidney disease in adults in primary and secondary care 2014 Update 2015 Adults 18+ with or at risk of developing chronic kidney disease Healthcare professionals Commissioners and providers People with chronic kidney disease and their families and carers systematic review NICE
USPSTF USA United States Preventive Services Task Force Final Recommendation statement, Chronic Kidney Disease: Screening 2012   asymptomatic adults without diagnosed CKD clinicians probably systematic review “The USPSTF reviewed evidence on screening for CKD, including evidence on screening, accuracy of screening, early treatment, and harms of screening and early treatment.” one recommendation, not graded
  1. GoR grade of recommendation, LoE level of evidence